Abstract
Background
The prevalence of obesity in patients with type 1 diabetes mellitus (T1DM) has been increasing. Metabolic bariatric surgery (MBS) has proven to be effective in treating patients with T2DM. However, evidence for the benefit of the procedure for patients with T1DM is still limited, particularly in terms of glycemic control, demonstrating the need for a systematic review investigating this.
Method
A systematic review was performed in accordance with the PRISMA guidelines. Outcome measures such as weight loss, remission of comorbidities, pre- and post-intervention insulin requirements, and HbA1c levels were extracted.
Results
Thirty studies were included with a total of 706 patients (F = 524, M = 74, N/A = 60). The mean age was 40.01 years. The mean weight and body mass index (BMI) were 112.76 kg and 40.88 kg/m2 (24–58.9) respectively. The common procedure performed was RYGB (n = 497 (70.4%)), followed by SG (n = 131 (18.6%)). The mean decrease of insulin requirements was 92.3 IU/day (36.2–174) preoperatively to a mean of 35.8 IU/day (5–75) post-operatively. No significant trend was found for changes in HbA1c levels. The main side effects were episodes of hypoglycemia and diabetic ketoacidosis (DKA); there was no mortality. The mean %EWL was 74.57% (60–90.5%) at ≥ 6 follow-up months. Reductions in comorbidities such as hypertension and cardiovascular disease (CVD) were recorded in multiple studies.
Conclusion
Patients with obesity and T1DM can expect significant weight loss, potential resolution of comorbidities, and reduction of insulin requirements, but it does not usually result in improved glycemic control. Based on current review, best choice of bariatric surgery in such patients cannot yet be established.
Graphical abstract
Similar content being viewed by others
References
Kashyap SR, Gatmaitan P, Brethauer S, et al. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med. 2010;77(7):468–76.
Koliaki C, Liatis S, le Roux CW, et al. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord. 2017;17:50.
Mobasseri M, Shirmohammadi M, Amiri T, et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98–115.
Stenström G, Gottsäter A, Bakhtadze E, et al. Latent autoimmune diabetes in adults definition prevalence β-cell function and treatment. Diabetes 1. 2005;54(2):S68–72.
Fellinger P, Fuchs D, Wolf P, et al. Overweight and obesity in type 1 diabetes equal those of the general population. Wiener Klinische Wochenschrift. 2019;131(3–4):55–60.
Czupryniak L, Wiszniewski M, Szymański D, et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg. 2010;20:506–8.
Mahawar KK, de Alwis N, Carr WRJ, Jennings N, Schroeder N, Small PK. Bariatric surgery in type 1 diabetes mellitus: a systematic review. Obesity surgery [Internet]. Obes Surg; 2016 [cited 2021 Dec 13];26:196–204. Available from: https://pubmed.ncbi.nlm.nih.gov/26452482/
Middelbeek RJ, James-Todd T, Cavallerano JD, Schlossman DK, Patti ME, Brown FM. Gastric bypass surgery in severely obese women with type 1 diabetes: anthropometric and cardiometabolic effects at 1 and 5 years postsurgery. Diabetes Care. 2015;38(7):e104–5.
Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW, Lam TK. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18(6):950–5.
Sarruf DA, Bonner-Weir S, Schwartz MW. New clues to bariatric surgery’s benefits. Nat Med. 2012;18(6):860–1.
Ichikawa H, Imoto H, Tanaka N, Musha H, Sawada S, Naitoh T, Kamei T, Unno M. Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report. Surg Case Rep. 2021;7(1):7.
Hironaka JY, Kitahama S, Sato H, Inoue M, Takahashi T, Tamori Y. Sleeve gastrectomy induced remission of slowly progressive type 1 diabetes in a morbidly obese Japanese patient. Intern Med. 2019;58(5):675–8.
Mohammed N, Buckley A, Elsheikh M, et al. Bariatric surgery in the treatment of patients with obesity and type 1 diabetes: A retrospective study of clinical data. Diabetes Obes Metab. 2021;23(7):1562–70.
Landau Z, Kowen-Sandbank G, Jakubowicz D, Raziel A, Sakran N, Zaslavsky-Paltiel I, Lerner-Geva L, Pinhas-Hamiel O. Bariatric surgery in patients with type 1 diabetes: special considerations are warranted. Ther Adv Endocrinol Metab. 2019. https://doi.org/10.1177/2042018818822207.
Uno K, Seki Y, Kasama K, et al. Mid-term results of bariatric surgery in morbidly obese Japanese patients with slow progressive autoimmune diabetes Asian Journal of Endoscopic Surgery [Internet]. John Wiley & Sons Ltd. 2018;11:238–43. https://doi.org/10.1111/ases.12443.
al Sabah S, al Haddad E, Muzaffar TH, et al. Laparoscopic sleeve gastrectomy for the management of type 1 diabetes mellitus. Obes Surg Springer, New York LLC. 2017;27:3187–93.
Vilarrasa N, Rubio MA, Miñambres I, et al. Long-term outcomes in patients with morbid obesity and type 1 diabetes undergoing bariatric surgery. Obes Surg Springer, New York LLC. 2017;27:856–63.
Faucher P, Poitou C, Carette C, et al. Bariatric surgery in obese patients with type 1 diabetes effects on weight loss and metabolic control. Obes Surg Springer, New York LLC. 2016;26:2370–8.
Rottenstreich A, Keidar A, Yuval JB, et al. Outcome of bariatric surgery in patients with type 1 diabetes mellitus our experience and review of the literature. Surg Endosc Springer, New York LLC. 2016;30:5428–33.
Maraka S, Kudva YC, Kellogg TA, et al. Bariatric surgery and diabetes: implications of type 1 versus insulin-requiring type 2. Obes. 2015;23:552–7.
Robert M, Belanger P, Hould FS, et al. Should metabolic surgery be offered in morbidly obese patients with type I diabetes? Surg Obes Relat Dis Elsevier Inc. 2015;11:798–805.
Blanco J, Jiménez A, Casamitjana R, et al. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery. Surg Obes Relat Dis. 2014;10:9–13.
Brethauer SA, Aminian A, Rosenthal RJ, Kirwan JP, Kashyap SR, Schauer PR. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care. 2014;37(3):e51–2.
Lannoo M, Dillemans B, Van Nieuwenhove Y, Fieuws S, Mathieu C, Gillard P, D’Hoore A, Van Der Schueren B. Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes. Diabetes Care. 2014;37(8):e173–4.
Tang A, Milner KL, Tonks K, Campbell L, Greenfield JR. Comment on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care 2014;37:e51-e52. Diabetes Care. American Diabetes Association Inc.; 2014;37:e248–9.
Ziemiański P, Lisik W, Marszałek RJ, et al. Improvement of graft function following Roux-en-Y gastric bypass surgery in a morbidly obese kidney recipient: a case report and literature review. Annal transplantation : Q Pol Transplantation Soc. 2014;19:639–42.
Chuang J, Zeller MH, Inge T, Crimmins N. Bariatric surgery for severe obesity in two adolescents with type 1 diabetes. Pediatrics. 2013;132(4):e1031–4.
Dirksen C, Jacobsen SH, Bojsen-Møller KN, Jørgensen NB, Naver LS, Hvolris LE, Worm D, Madsbad S, Holst JJ, Hansen DL. Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report. Obes Res Clin Pract. 2013;7(4):e269–74.
Fuertes-Zamorano N, Sánchez-Pernaute A, et al. Cirugía bariátrica en diabetes mellitus tipo 1; experiencia a largo plazo en dos casos. Nutr Hosp. 2013;28:1333–6.
Reyes Garcia R, Romero Muñoz M, GalbisVerdú H. Bariatric surgery in type 1 diabetes. Endocrinología y Nutrición (English Edition). 2013;60:46–7.
Manning SB, Pucci A, Batterham RL, Finer N. Latent autoimmune diabetes in adults presenting as diabetes "recurrence" after bariatric surgery: a case report. Diabetes Care. 2013;36(8):e120.
Raab H, Weiner RA, Frenken M, Rett K, Weiner S. Obesity and metabolic surgery in type 1 diabetes mellitus. Nutr Hosp. 2013;28 Suppl 2:31–4.
Garciacaballero M, Martínez-Moreno JM, Toval JA, Miralles F, Mínguez A, Osorio D, Mata JM, Reyes-Ortiz A. Improvement of C peptide zero BMI 24-34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA). Nutr Hosp. 2013;28 Suppl 2:35–46.
Mendez CE, Tanenberg RJ, Pories W. Diabetes, metabolic syndrome and obesity: targets and therapy dovepress outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report [Internet]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2010. Available from: http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal. Accessed 1 Oct 2022
Fernandez-Ranvier G, Meknat A, Guevara DE, Alenazi N, Ruiz H, Ritondale O, et al. The role of bariatric surgery in patients with obesity and type 1 diabetes mellitus. Bariatric Surgical Practice and Patient Care. 2020;15(1):46–50.
Moreno-Fernandez J, Chico A. Bariatric surgery results in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion therapy. Endocrinol y Nutrición Elsevier Doyma. 2016;63:571–2.
Höskuldsdóttir G, Ekelund J, Miftaraj M, Wallenius V, Ottosson J, Näslund I, et al. Potential benefits and harms of gastric bypass surgery in obese individuals with type 1 diabetes: a nationwide, matched, observational cohort study. Diabetes Care. 2020;43(12):3079–85.
Vendrame F, Casu A, Pratley RE, Calhoun P. 2016-P: bariatric surgery may improve glucose control among patients with type 1 diabetes. Diabetes (New York, N.Y.). 2016;69(Supplement 1):2020–06. https://doi.org/10.2337/db20-2016-P.
Ashrafian H, Harling L, Toma T, Athanasiou C, Nikiteas N, Efthimiou E, et al. Type 1 diabetes mellitus and bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2016;26(8):1697–704.
Chow A, Switzer NJ, Dang J, Shi X, de Gara C, Birch DW, et al. A systematic review and meta-analysis of outcomes for type 1 diabetes after bariatric surgery. J Obes. 2016;2016:6170719.
Purnell JQ, Zinman B, Brunzell JD; DCCT/EDIC Research Group. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation. 2013;127(2):180–7.
Khawandanah J. Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors. Nutr Diabetes. 2019;9(1):33.
Madsbad S, Faber OK, Binder C, McNair P, Christiansen C, Transbøl I. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes. 1978;27(Suppl 1):262–4.
Levetan C. Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes. J Diabetes. 2010;2(2):76–84.
Korakas E, Kountouri A, Raptis A, Kokkinos A, Lambadiari V. Bariatric surgery and type 1 diabetes: unanswered questions. Front Endocrinol. 2020. https://doi.org/10.3389/fendo.2020.525909.
Seissler J. Latent (slowly progressing) autoimmune diabetes in adults. Curr Diab Rep. 2008;8(2):94–100.
Aminian A, Kashyap SR, Burguera B, et al. Incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery. Diabetes Care. 2016;39(4):e50–3.
Kirwan JP, Aminian A, Kashyap SR, et al. Bariatric surgery in obese patients with type 1 diabetes. Diabetes Care. 2016;39(6):941–8.
Parmar CD, Zakeri R, Mahawar K. A systematic review of one anastomosis/mini gastric bypass as a metabolic operation for patients with body mass index ≤ 35 kg/m2. Obes Surg. 2020;30(2):725–35.
Parmar CD, Gan J, Stier C, et al. One anastomosis/mini gastric bypass (OAGB-MGB) as revisional bariatric surgery after failed primary adjustable gastric band (LAGB) and sleeve gastrectomy (SG): a systematic review of 1075 patients. Int J Surg. 2020;81:32–8.
Parmar CD, Bryant C, Luque-de-Leon E, et al. One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m2: a systematic review comparing it with Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2019;29(9):3039–46. https://doi.org/10.1007/s11695-019-04034-9 (PMID: 31250385).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
This type of study does not need ethical approval.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• BS leads to significant weight loss and changes in insulin requirements, as well as a potential resolution of comorbidities.
• No significant evidence is speaking for improved glycemic control, apart from in patients with latent autoimmune diabetes in adults (LADA).
• Risk–benefit ratio needs to be critically evaluated due to the possibility of severe side effects.
• Difficult to recommend choice of bariatric surgery in these patients based on published evidence.
• Need for comprehensive clinical trials to assess safety and efficacy of different bariatric procedures in this cohort of patients.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Parmar, C., Appel, S., Lee, L. et al. Choice of Bariatric Surgery in Patients with Obesity and Type 1 Diabetes Mellitus? an Up-to-Date Systematic Review. OBES SURG 32, 3992–4006 (2022). https://doi.org/10.1007/s11695-022-06321-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-022-06321-4